Table 1.
Prevalence of psychiatric disorders, self-harm, and suicide.
| Selected variable (ICD 10 code) | Male gender | Female gender | Total (n, %) | p | Bonferroni-Holm significance level |
|---|---|---|---|---|---|
| Social welfare payment | N = 301 (44.3%) | N = 85 (50.3%) | N = 386 (45.5%) | 0.163 | NA |
| Death from suicide X60–X84 | N = 7 (1%) | N = 0 (0%) | N = 7 (0.8%) | 1.000** | NA |
| Death from self-harm of unknown intent Y10–Y34 | N = 2 (0.3%) | N = 0 (0%) | N = 2 (0.2%) | 1.000*** | NA |
| Non-lethal intentional self-harm X60–X84* | N = 71 (10.5%) | N = 31 (18.3%) | N = 102 (12%) | 0.005 | 0.013 |
| Non-lethal self-harm of unknown intent Y10–Y34 | N = 16 (2.4%) | 6 (3.6%) | 22 (2.6%) | 0.415** | NA |
| SUD F11–F19 | N = 154 (22.7%) | N = 41 (24.3%) | 195 (23.0%) | 0.662 | NA |
| Alcohol, F10 | N = 188 (27.7%) | 45 (26.6%) | 233 (27.5%) | 0.782 | NA |
| Opioids, F11 | N = 21 (3.1%) | 6 (3.6%) | 27 (3.2%) | 0.762 | NA |
| Cannabinoids, F12 | N = 34 (5.0%) | 7 (4.1%) | 41 (4.8%) | 0.639 | NA |
| Sedatives, F13 | N = 39 (5.7%) | 18 (10.7%) | 57 (6.7%) | 0.023 | 0.005 |
| Cocaine, F14 | N = 5 (0.7%) | 1 (0.6%) | 6 (0.7%) | 1.000** | NA |
| Other stimulants, F15 | N = 18 (2.7%) | 1 (0.6%) | 19 (2.2) | 0.146* | NA |
| Hallucinogens, F16 | N = 4 (0.6%) | 2 (1.2%) | 6 (0.7%) | 0.343** | NA |
| Tobacco, F17 | N = 17 (2.5%) | 7 (4.1%) | 24 (2.8%) | 0.296* | NA |
| Volatile solvents, F18 | N = 1 (0.1%) | 0 (0.0%) | 1 (0.1%) | 1.000** | NA |
| Multiple drug use and psychoactives, F19 | N = 88 (13%) | 24 (14.2%) | 112 (13.2%) | 0.670 | NA |
| Psychiatric comorbidity F diagnosis (exluding F63.0)* | N = 572 (84.2%) | N = 159 (94.1%) | N = 731 (86.2%) | <0.001 | 0.001 |
| Bipolar disorder F30–F31* | N = 69 (10.2%) | N = 35 (20.7%) | N = 104 (12.3%) | <0.001 | 0.006 |
| Anxiety disorder F40–F48* | N = 352 (51.0%) | N = 113 (66.9%) | N = 465 (54.8%) | <0.001 | 0.007 |
| Depressive disorders F32–F33* | N = 280 (41.2%) | N = 370 (43.6%) | N = 379 (43.6%) | 0.005 | 0.013 |
| Other depressive disorder F34–F39 | N = 23 (3.4%) | N = 9 (5.3%) | 32 (3.8%) | 0.237 | NA |
| Psychotic disorder F20–F29 | N = 61 (9.0%) | N = 7 (4.1%) | N = 68 (8.0%) | 0.038 | 0.017 |
| Personality disorder, F60–F62 excluding antiscoial personality disorder (F602)* | N = 80 (11.8%) | N = 53 (31.4%) | N = 133 (15.7%) | <0.001 | 0.008 |
| Antisocial personality disorder F602 | N = 13 (1.9%) | N = 1 (0.6%) | N = 15 (1.7%) | 0.227 | NA |
Gender comparison through Pearson Chi square test and Fisher's test when needed. Significant results at p level 0.05 were then tested with the Bonferroni-Holm procedure dividing the factors into four groups; socioeconomic factors (n = 1), self-harm (n = 4), substance use disorders (n = 11), and psychiatric comorbidities (n = 8) with an alfa level at 0.05. N = 848. AUD, alcohol use disorder; SUD, substance abuse disorder.
Significant at the alfa level of 0.05 after Bonferroni-Holm correction.
NA, not applicable.
One of the cells (25%) had expected count <5. Results are thus from Fisher's test, two-sided results displayed.
Two of the cells (50%) had expected count <5. Results are thus from Fisher's test, two-sided results displayed.